S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
OTCMKTS:UCLE

US Nuclear Stock Forecast, Price & News

$0.36
-0.02 (-5.26 %)
(As of 10/19/2021 03:54 PM ET)
Add
Compare
Today's Range
$0.35
▼
$0.40
50-Day Range
$0.35
▼
$0.66
52-Week Range
$0.10
▼
$1.38
Volume128,888 shs
Average Volume86,343 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive UCLE News and Ratings via Email

Sign-up to receive the latest news and ratings for US Nuclear and its competitors with MarketBeat's FREE daily newsletter.


US Nuclear logo

About US Nuclear

US Nuclear Corp. engages in the design, building, and manufacture of radiation safety and monitoring instruments. It operates through the Optron, Overhoff, and Corporate segments. The Optron segment is located in Canoga Park, California. The Overhoff segment is located in located in Milford, Ohio. The company was founded on February 14, 2012 and is headquartered in Canoga Park, CA.

Headlines

UN Atomic Agency Head to Visit Iran As Pressure Ramps Up on Revival of Nuclear Deal
October 19, 2021 |  msn.com
Facts on India's nuclear power and list of nuclear research centres in India
October 19, 2021 |  msn.com
UK Government to fund nuclear plant in net zero push
October 19, 2021 |  msn.com
North Korea launched a ballistic missile into Sea of Japan amid a US offer to resume diplomacy
October 19, 2021 |  businessinsider.com
China reportedly tests a nuclear-capable hypersonic missile
October 18, 2021 |  a.msn.com
US accuses China of deviating from ‘minimal nuclear deterrence’ strategy
October 18, 2021 |  msn.com
SC nuclear advisers back atomic fuel plant with history of environmental violations
October 18, 2021 |  msn.com
White House mum on reports of China testing nuclear missile, says admin welcomes 'stiff competition'
October 18, 2021 |  msn.com
Did the US betray France, or is outrage over a submarine deal simply sour grapes?
October 18, 2021 |  msn.com
US Nuclear’s Partner, Grapheton, Appoints New Top Gun
October 18, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
OTCMKTS:UCLE
Previous Symbol
NASDAQ:UCLE
CUSIP
N/A
CIK
1543623
Web
new.usnuclearcorp.com
Phone
(818) 883-7043
Employees
6
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Market Cap
N/A
Next Earnings Date
11/29/2021 (Estimated)
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












US Nuclear (OTCMKTS:UCLE) Frequently Asked Questions

What stocks does MarketBeat like better than US Nuclear?

Wall Street analysts have given US Nuclear a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but US Nuclear wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting US Nuclear?

US Nuclear saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 9,400 shares, an increase of 30.6% from the September 15th total of 7,200 shares. Based on an average trading volume of 110,500 shares, the days-to-cover ratio is presently 0.1 days.
View US Nuclear's Short Interest.

When is US Nuclear's next earnings date?

US Nuclear is scheduled to release its next quarterly earnings announcement on Monday, November 29th 2021.
View our earnings forecast for US Nuclear.

How has US Nuclear's stock been impacted by Coronavirus (COVID-19)?

US Nuclear's stock was trading at $0.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, UCLE shares have decreased by 53.2% and is now trading at $0.36.
View which stocks have been most impacted by COVID-19.

Who are US Nuclear's key executives?

US Nuclear's management team includes the following people:
  • Robert I. Goldstein, Chairman, President & Chief Executive Officer
  • Richard Landry, COO & Director-Investor Relations
  • Rachel Boulds, Chief Financial Officer & Secretary

What other stocks do shareholders of US Nuclear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other US Nuclear investors own include IntelGenx Technologies (IGXT), Acasti Pharma (ACST), Aethlon Medical (AEMD), General Cannabis (CANN), (HSDT), KemPharm (KMPH), Naked Brand Group (NAKD), Ocugen (OCGN), Plug Power (PLUG) and QuoteMedia (QMCI).

What is US Nuclear's stock symbol?

US Nuclear trades on the OTCMKTS under the ticker symbol "UCLE."

How do I buy shares of US Nuclear?

Shares of UCLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is US Nuclear's stock price today?

One share of UCLE stock can currently be purchased for approximately $0.36.

How many employees does US Nuclear have?

US Nuclear employs 6 workers across the globe.

What is US Nuclear's official website?

The official website for US Nuclear is new.usnuclearcorp.com.

Where are US Nuclear's headquarters?

US Nuclear is headquartered at 7051 Eton Ave, CANOGA PARK, CA 91303-2112, United States.

How can I contact US Nuclear?

US Nuclear's mailing address is 7051 Eton Ave, CANOGA PARK, CA 91303-2112, United States. The company can be reached via phone at (818) 883-7043.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.